As of November 2024, Alaunos Therapeutics has a market cap of $750.76M. This makes Alaunos Therapeutics the world's 9184th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $421.89M | 66.98% |
2023 | $252.66M | -89.23% |
2022 | $2.35B | -40.37% |
2021 | $3.93B | -56.75% |
2020 | $9.10B | -46.61% |
2019 | $17.04B | 152.41% |
2018 | $6.75B | -54.83% |
2017 | $14.94B | -22.62% |
2016 | $19.31B | -35.62% |
2015 | $29.99B | 63.91% |
2014 | $18.30B | 1652.30% |
2013 | $1.04B | 4.33% |
2012 | $1.00B | -5.67% |
2011 | $1.06B | -5.36% |
2010 | $1.12B | 57.43% |
2009 | $712.26M | 410.34% |
2008 | $139.56M | -83.62% |
2007 | $851.82M | -40.70% |
2006 | $1.44B | 83.69% |
2005 | $782.04M | - |